Anticoagulants, Antiplatelets, and Thrombolytics

Author:   Shaker A. Mousa
Publisher:   Humana Press Inc.
Edition:   2004 ed.
Volume:   93
ISBN:  

9781617373466


Pages:   320
Publication Date:   09 November 2010
Format:   Paperback
Availability:   Out of stock   Availability explained


Our Price $314.16 Quantity:  
Add to Cart

Share |

Anticoagulants, Antiplatelets, and Thrombolytics


Add your own review!

Overview

1This collection of review articles highlights the latest development of antithrombotics and provides proven experimental methods for the further development of new and improved anticoagulants. Among the cutting-edge developments reviewed are the novel usage of low molecular weight heparins, such antithrombin agents as the hirudin, and such antiplatelet drugs as the GPIIb/IIIa inhibitors and ADP receptor antagonists. Additional innovations discussed include aspirin and clopidogrel, the expanded use of polytherapeutic approaches, antiproteases (factors IIa, Xa, and VIIa), tissue factor targeting, platelet receptor targeting, and antithrombin III modulation.

Full Product Details

Author:   Shaker A. Mousa
Publisher:   Humana Press Inc.
Imprint:   Humana Press Inc.
Edition:   2004 ed.
Volume:   93
Weight:   0.462kg
ISBN:  

9781617373466


ISBN 10:   161737346
Pages:   320
Publication Date:   09 November 2010
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Out of Print
Availability:   Out of stock   Availability explained

Table of Contents

Highlights of Latest Advances in Antithrombotics Shaker A. Mousa Antiplatelet, Anticoagulant, and Thrombolytic Drug Interactions Omer Iqbal and Shaker A. Mousa Evaluation of Platelet Antagonists in In Vitro Flow Models of Thrombosis Owen J. T. McCarty, James P. Abulencia, Shaker A. Mousa, and Konstantinos Konstantopoulos Heparin and Low Molecular Weight Heparin in Thrombosis, Cancer, and Inflammatory Diseases Shaker A. Mousa Are Low Molecular Weight Heparins the Same? Shaker A. Mousa Antithrombotic Drugs for the Treatment of Heparin-Induced Thrombocytopenia Walter P. Jeske and Jeanine M. Walenga Laboratory Methods for Heparin-Induced Thrombocytopenia Margaret Prechel, Walter P. Jeske, and Jeanine M. Walenga Factor Xa Inhibitors Jeanine M. Walenga, Walter P. Jeske, Debra Hoppensteadt, and Jawed Fareed Tissue Factor/VIIa in Thrombosis and Cancer Shaker A. Mousa Tissue Factor Pathway Inhibitor in Thrombosis and Beyond Shaker A. Mousa, Jawed Fareed, Omer Iqbal, and Brigitte Kaiser Cell Adhesion Molecules: Potential Therapeutic and Diagnostic Implications Shaker A. Mousa Development and Applications of Animal Models of Thrombosis Ronald J. Shebuski, Larry R. Bush, Alison Gagnon, Liguo Chi, and Robert J. Leadley, Jr. A Survey of Venous Thrombosis Models Walter P. Jeske, Omer Iqbal, Jawed Fareed, and Brigitte Kaiser Arixtra(R) (Fondaparinux Sodium) Shaker A. Mousa Oral Thrombin Inhibitor Ximelagatran Shaker A. Mousa Pharmacogenomics and Coagulation Disorders Omer Iqbal Guidelines for Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Hikmat Abdel-Razeq, Mohamad Qari, Jorgen Kristensen, Hussein Alizeidah, Faisal Al-Sayegh, Mahmoud Marashi, Abdulaziz Alzeer, Omar Al-Amoudi, Hatem Qutub, Abdel-Aziz Al-Humiadi, Steen Husted, and Shaker A. Mousa on behalf of the GCC Thrombosis Study Group Index

Reviews

From the reviews: This book contains a number of informative topics on the latest advances in the field. ! Basic science is completed with clinical results. Very complete guidelines for treatment of deep thrombosis and pulmonary embolism ends the book. This recommendable book ! provides a clinical audience with a complete update on a major field in medicine. (Michel Telerman, Acta Cardiologica, April, 2005)


Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List